Targeting CDK12 is a novel therapeutic strategy through disrupting oncogene associated super‐enhancers in metastatic colorectal cancer
Saved in:
Main Authors: | Zhijian Kuang (Author), Chun‐Ming Wong (Author) |
---|---|
Format: | Book |
Published: |
Wiley,
2022-12-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Targeting Super-Enhancers as a Therapeutic Strategy for Cancer Treatment
by: Yi He, et al.
Published: (2019) -
Pathogenic role of super-enhancers as potential therapeutic targets in lung cancer
by: Zhiyuan Yao, et al.
Published: (2024) -
Oncogenic alterations in advanced NSCLC: a molecular super-highway
by: Alex Friedlaender, et al.
Published: (2024) -
Cyclin‐dependent kinase 12‐mediated super‐enhancers as promising targets in cancer therapy
by: Fuda Xie, et al.
Published: (2022) -
CXCR4 in breast cancer: oncogenic role and therapeutic targeting
by: Xu C, et al.
Published: (2015)